Aripiprazole
آریپیپرازول
🧠 Nervous SystemAtypical antipsychotic
Market / country: 🇺🇸 USA
Abilify (US)
🧮 Dose calculator
Irritability associated with autistic disorder · Regimen source: FDA Aripiprazole · 2.4
- • 2 → 5 mg, then 10 or 15 if needed; changes up to 5 mg at intervals of at least one week. FDA Aripiprazole · 2.4
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Known hypersensitivity to aripiprazole. FDA Aripiprazole · 4
Warnings
- • Boxed warning: increased mortality in elderly with dementia-related psychosis; suicidal thoughts with antidepressants. FDA Aripiprazole · WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS and SUICIDAL THOUGHTS AND BEHAVIORS WITH ANTIDEPRESSANT DRUGS
- • Adjust dose with CYP2D6/CYP3A4 inhibitors or inducers (Table 1). FDA Aripiprazole · 2.6
Formulations
- 2 mg tablet — tablet 🇺🇸 USA FDA Aripiprazole · 3
- 5 mg tablet — tablet 🇺🇸 USA FDA Aripiprazole · 3
- 10 mg tablet — tablet 🇺🇸 USA FDA Aripiprazole · 3
- 15 mg tablet — tablet 🇺🇸 USA FDA Aripiprazole · 3
- 20 mg tablet — tablet 🇺🇸 USA FDA Aripiprazole · 3
- 30 mg tablet — tablet 🇺🇸 USA FDA Aripiprazole · 3
- Abilify Maintena 400 mg vial or prefilled syringe (also 300 mg) — powder for injection 🇺🇸 USA FDA Abilify Maintena · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Aripiprazole · 8.1
“Risk Summary Neonates exposed to antipsychotic drugs, including aripiprazole, during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms following delivery (see Clinical Considerations) .”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Aripiprazole · 8.2
“Risk Summary Aripiprazole is present in human breast milk.”
- 👶 ChildrenDangerous / avoid
Boxed warning in the label about children. FDA Aripiprazole · Boxed Warning
“Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies.”
- 👴 Older adultsDangerous / avoid
Label: serious warning or avoid in older adults. FDA Aripiprazole · Boxed Warning
“Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA204838
- DailyMed (FDA label)FDA Aripiprazole
- MedlinePlus (NIH)AripiprazoleAripiprazole Injection
- WHO ATC/DDDN05AX12
- Darooyab (Iran)Aripiprazole
🇮🇷 Registered in Iran Darooyab · G-1228/Aripiprazole
Dosage forms with Iranian generic codes, per Darooyab.
- 05519 · ARIPIPRAZOLE 10MG TAB · قرص آریپیپرازول ۱۰ میلیگرم
- 05521 · ARIPIPRAZOLE 15MG TAB · قرص آریپیپرازول ۱۵ میلیگرم
- 07178 · ARIPIPRAZOLE 30MG TAB · قرص آریپیپرازول ۳۰ میلیگرم
- 10392 · ARIPIPRAZOLE 5MG TAB · قرص آریپیپرازول ۵ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Aripiprazole · 3FDA Abilify Maintena · 3FDA Aripiprazole · 2.4FDA Aripiprazole · 2.5FDA Aripiprazole · 2.1FDA Abilify Maintena · 2.2FDA Abilify Maintena · 2.1FDA Abilify Maintena · 2.4FDA Aripiprazole · 4FDA Aripiprazole · WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS and SUICIDAL THOUGHTS AND BEHAVIORS WITH ANTIDEPRESSANT DRUGSFDA Aripiprazole · 2.6FDA Aripiprazole · 8.1FDA Aripiprazole · 8.2FDA Aripiprazole · Boxed WarningFDA Aripiprazole · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1228/Aripiprazole
- Clinical review⚠ Unverified